SRXN1 and neoplasm: Prostate transcriptome data from Pb-Cre4; Ptenf/f mice comparing WT to tumor samples (PIN, MT, and AT) showed that the relative mRNA expression of Srxn1 increases progressively and significantly during tumor progression in all prostatic lobes, with p < 0.001 (Figure 2(a)).